Journal
POLYMER COMPOSITES
Volume 39, Issue 2, Pages 544-552Publisher
WILEY
DOI: 10.1002/pc.23967
Keywords
-
Categories
Funding
- Ministry of Higher Education of Malaysia (MOHE) [GP-IPB/2013/9425800]
- Faculty of Pharmacy at Isra University
Ask authors/readers for more resources
Chitosan nanoparticles (CSNPs) and perindopril erbumine (PE)-loaded chitosan nanoparticles (PE-CSNPs) were prepared using the ionic gelation method with tripolyphosphate (TPP) as a crosslinking agent. The XRD pattern of the PE-CSNP nanocomposite shows suppression of the peaks corresponding to crystallized chitosan due to its conversion to the amorphous form after crosslinking and PE loading. The presence of the drug in the nanocomposite was confirmed by a shift in the FTIR transmittance peak from 1,289 to 1,279 cm(-1). The mean diameter of the PE-CSNP nanocomposite was 44 nm. Analysis of the ultraviolet spectrum indicated that the loading efficiency and the encapsulation efficiency were 30.5% and 94.1%, respectively. The in vitro drug release profile was also determined by ultraviolet spectroscopy, which showed a sustained release over a period of 2 h (99.8%), starting with initial burst release (40% in 10 min). According to our results, no IC50 (the half maximal inhibitory concentration) against the 3T3 cell line was found for free PF or the PE-CSNP nanocomposite up to 100 g mL(-1). POLYM. COMPOS., 39:544-552, 2018. (c) 2016 Society of Plastics Engineers
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available